Compare · CGC vs CRON
CGC vs CRON
Side-by-side comparison of Canopy Growth Corporation (CGC) and Cronos Group Inc. (CRON): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both CGC and CRON operate in Medicinal Chemicals and Botanical Products (Health Care), so they compete in similar markets.
- CRON is the larger of the two at $1.11B, about 6.1x CGC ($183.7M).
- CRON has been more active in the news (5 items in the past 4 weeks vs 3 for CGC).
- CGC has more recent analyst coverage (19 ratings vs 11 for CRON).
- Company
- Canopy Growth Corporation
- Cronos Group Inc.
- Price
- -
- -
- Market cap
- $183.7M
- $1.11B
- 1M return
- -35.03%
- -
- 1Y return
- -62.27%
- -
- Industry
- Medicinal Chemicals and Botanical Products
- Medicinal Chemicals and Botanical Products
- Exchange
- NASDAQ
- NASDAQ
- IPO
- News (4w)
- 3
- 5
- Recent ratings
- 19
- 11
Canopy Growth Corporation
Canopy Growth Corporation, together with its subsidiaries, engages in the production, distribution, and sale of cannabis and hemp-based products for recreational and medical purposes primarily in Canada, the United States, and Germany. It operates through two segments, Global Cannabis and Other Consumer Products. The company's products include dried cannabis flowers, oils and concentrates, and softgel capsules. It offers its products under the Tweed, Quatreau, Deep Space, Spectrum Therapeutics, First & Free, TWD, This Works, BioSteel, DNA Genetics CraftGrow, Tokyo Smoke, DOJA, Van der Pop, and Bean & Bud brands. The company also provides growth capital and a strategic support platform that pursues investment opportunities in the global cannabis sector. Canopy Growth Corporation has a clinical research partnership with NEEKA Health Canada and NHL Alumni Association to examine the efficacy of CBD-based therapies as part of the mitigation of persistent post-concussion symptoms. The company was formerly known as Tweed Marijuana Inc. and changed its name to Canopy Growth Corporation in September 2015. Canopy Growth Corporation is headquartered in Smiths Falls, Canada.
Cronos Group Inc.
Cronos Group Inc. operates as a cannabinoid company. It manufactures, markets, and distributes hemp-derived supplements and cosmetic products through e-commerce, retail, and hospitality partner channels under the Lord Jones and Happy Dance brands in the United States. The company is also involved in the cultivation, manufacture, and marketing of cannabis and cannabis-derived products for the medical and adult-use markets. It sells cannabis and cannabis products, including dried cannabis, pre-rolls, and cannabis extracts through wholesale and direct-to-client channels under its wellness platform, PEACE NATURALS; and operates under two adult-use brands, COVE and Spinach. The company also exports dried cannabis and cannabis oils to Germany, Israel, and Australia. Cronos Group Inc. was founded in 2012 and is based in Toronto, Canada.
Latest CGC
- Canopy Growth Corporation filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits
- Canopy Growth Reports Second Quarter Fiscal Year 2027 Financial Results; Net Revenue Growth of 22% Led by a 141% Increase in International Markets Cannabis
- SEC Form 10-Q filed by Canopy Growth Corporation
- Canopy Growth Announces Results of 2026 Annual General and Special Meeting of Shareholders
- SEC Form 8-K filed by Canopy Growth Corporation
- Canopy Growth to Report Second Quarter Fiscal 2027 Financial Results on November 6, 2026
- SEC Form DEFA14A filed by Canopy Growth Corporation
- SEC Form 8-K filed by Canopy Growth Corporation
- Canopy Growth’s Smiths Falls Facility Becomes Canada’s Only EU GMP-Certified Site Combining Softgel Manufacturing With Primary Packaging of Softgels, Oral Liquids and Dried Cannabis Flower
- SEC Form DEFA14A filed by Canopy Growth Corporation
Latest CRON
- Almonty Strengthens Board with Two Independent Directors and Announces Intention to Pursue a Secondary Listing on the Korean Exchange
- Officer Wagner Adam converted options into 20,242 shares, increasing direct ownership by 19% to 124,229 units (SEC Form 4)
- SEC Form 10-Q filed by Cronos Group Inc.
- Cronos Group Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits
- Cronos Group Reports 2026 Third Quarter Results
- SEC Form 4 filed by Cronos Group Inc.
- SEC Form 3 filed by Cronos Group Inc.
- SEC Form 8-K filed by Cronos Group Inc.
- Cronos Completes Acquisition of CanAdelaar, Europe’s Largest Adult-Use Cannabis Company
- Fan-Favorite and Limited-Edition Spinach® Green Apple-Flavored Products are Returning for the Fall Season